Results 81 to 90 of about 211,753 (383)

A pharmacovigilance study in the department of medicine of a university teaching hospital.

open access: yesPharmacy Practice, 2007
The aim of the present study was to monitor adverse drug reactions (ADRs) in the Medicine out patient department (OPD) of a University Teaching Hospital.Method: A prospective evaluation of the ADRs reported in the Department of Medicine of our University
Sharma H   +5 more
doaj  

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database [PDF]

open access: gold, 2023
Dongxuan Li   +11 more
openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Pharmaceutical services in a Mexican pain relief and palliative care institute

open access: yesPharmacy Practice, 2007
Neither the purchase nor the distribution of pharmaceuticals in hospitals and community pharmacies in Mexico is under the care of pharmacists. Some are under control of physicians.This report presents the results of the implementation of somef ...
Escutia Gutierrez R   +5 more
doaj  

Reacciones adversas a medicamentos en una población colombiana, 2007-2013: análisis de bases de datos

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2016
Introducción. La detección de las reacciones adversas a medicamentos es cada vez más importante en la práctica clínica. Objetivo. Determinar la frecuencia de reacciones adversas a medicamentos y de los casos sospechosos de tales reacciones, en la ...
Jorge Enrique Machado-Alba   +3 more
doaj   +1 more source

Exposure to potential drug-antimicrobial agent interactions in primary health care [PDF]

open access: yesVojnosanitetski Pregled, 2018
Background/Aim. Drug-drug interactions involving antimicrobials present important and often unrecognized complications of pharmacotherapy which can be prevented.
Nikolić Božana   +3 more
doaj   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Awareness among nurses about reporting of adverse drug reactions in Sweden

open access: yesDrug, Healthcare and Patient Safety, 2012
Elisabet Ekman,1–3 Göran Petersson,2 Sven Tågerud,3 Martin Bäckström41Regional Pharmacovigilance Unit, R & D Centre Skåne, Skåne University Hospital, Lund, 2eHealth Institute ...
Ekman E   +3 more
doaj  

Learning signals of adverse drug-drug interactions from the unstructured text of electronic health records. [PDF]

open access: yes, 2013
Drug-drug interactions (DDI) account for 30% of all adverse drug reactions, which are the fourth leading cause of death in the US. Current methods for post marketing surveillance primarily use spontaneous reporting systems for learning DDI signals and ...
Bauer-Mehren, Anna   +4 more
core   +5 more sources

Assessing the 2004-2018 fentanyl misusing issues reported to an international range of adverse reporting systems [PDF]

open access: yes, 2019
© 2019 Schifano, Chiappini, Corkery and Guirguis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
Chiappini, Stephania   +3 more
core   +4 more sources

Home - About - Disclaimer - Privacy